Royalty Pharma Plc (RPRX) — Financial Flexibility Index
Royalty Pharma Plc (RPRX) has a Financial Flexibility Index of 0.08x as of March 2026. Free cash flow of $760.54 Million (operating CF $760.54 Million minus capex $0.00) represents 0% of total liabilities ($9.88 Billion). Also explore how fast is Royalty Pharma Plc growing its equity to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Royalty Pharma Plc Financial Flexibility Index (2002–2025)
Historical Financial Flexibility Index trend for Royalty Pharma Plc across 14 annual periods. Check Royalty Pharma Plc PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Royalty Pharma Plc (2002–2025)
Year-by-year free cash flow to debt coverage for Royalty Pharma Plc. For the full company profile including market capitalisation, see RPRX market cap overview.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.25x | $2.49 Billion | $2.49 Billion | $9.91 Billion | ▼ -28.5% |
| 2024 | 0.35x | $2.77 Billion | $2.77 Billion | $7.88 Billion | ▼ -56.6% |
| 2023 | 0.81x | $5.10 Billion | $2.99 Billion | $6.30 Billion | ▲ +41.1% |
| 2022 | 0.57x | $4.19 Billion | $2.14 Billion | $7.29 Billion | ▲ +106.8% |
| 2021 | 0.28x | $2.02 Billion | $2.02 Billion | $7.27 Billion | ▼ -59.8% |
| 2020 | 0.69x | $4.23 Billion | $2.03 Billion | $6.12 Billion | ▲ +28.6% |
| 2019 | 0.54x | $3.39 Billion | $1.67 Billion | $6.31 Billion | ▲ +94.0% |
| 2018 | 0.28x | $1.89 Billion | $1.62 Billion | $6.82 Billion | ▼ -48.5% |
| 2017 | 0.54x | $3.71 Billion | $1.42 Billion | $6.90 Billion | ▲ +20862.9% |
| 2016 | 0.00x | $-15.58 Million | $-15.58 Million | $6.02 Billion | ▲ +37.5% |
| 2015 | 0.00x | $-25.33 Million | $-25.33 Million | $6.12 Billion | ▲ +100.0% |
| 2014 | -10.03x | $-29.33 Million | $-29.33 Million | $2.92 Million | ▼ -148.7% |
| 2003 | 20.61x | $11.15 Million | $11.15 Million | $541.00K | ▲ +25.9% |
| 2002 | 16.37x | $8.49 Million | $8.45 Million | $519.00K | — |